Inventor · disambiguated record
Viyyoor M. Girijavallabhan
Also filed as: GIRIJAVALLABHAN VIYYOOR · GIRIJAVALLABHAN VIYYOOR M · GIRIJAVALLABHAN VIYYOOR MOOPIL
130 granted patents·12 pending applications·3,241 citations·filing 1977–2011
99Inventor score
Top patents by PatentIndex Score
142 records- 0198US6838475B2Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jan 4, 2005·121 cites·43 claims
- 0297US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0397US5272167APharmaceutically active compoundsSCHERING CORP·Filed 1990·Granted Dec 21, 1993·104 cites·6 claims
- 0496US7186747B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 6, 2007·47 cites·31 claims
- 0596US6911428B2Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jun 28, 2005·124 cites·20 claims
- 0696US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0796US6372747B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Apr 16, 2002·93 cites·20 claims
- 0895US7425576B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Sep 16, 2008·20 cites·24 claims
- 0995US7205330B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2005·Granted Apr 17, 2007·54 cites·29 claims
- 1095US7173057B2Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virusSCHERING CORP·Filed 2005·Granted Feb 6, 2007·44 cites·29 claims
- 1195US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 1295US6846802B2Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moietiesSCHERING CORP·Filed 2001·Granted Jan 25, 2005·124 cites·21 claims
- 1395US6239140B1Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1998·Granted May 29, 2001·64 cites·4 claims
- 1495US5459144APharmaceutically active compoundsSCHERING CORP·Filed 1993·Granted Oct 17, 1995·64 cites·3 claims
- 1594US7423058B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2006·Granted Sep 9, 2008·15 cites·22 claims
- 1694US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 1794US6919341B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2003·Granted Jul 19, 2005·65 cites·17 claims
- 1894US6914122B2Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moietiesSCHERING CORP·Filed 2001·Granted Jul 5, 2005·89 cites·36 claims
- 1994US6432959B1Inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 1999·Granted Aug 13, 2002·75 cites·6 claims
- 2094US5661151ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Aug 26, 1997·69 cites·13 claims
- 2194US4851423APharmaceutically active compoundsSCHERING CORP·Filed 1986·Granted Jul 25, 1989·86 cites·21 claims
- 2293US7442695B2Depeptidized inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2007·Granted Oct 28, 2008·22 cites·20 claims
- 2393US7342041B23,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 11, 2008·28 cites·34 claims
- 2493US7192957B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 20, 2007·28 cites·28 claims
- 2593US6403564B1Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 1999·Granted Jun 11, 2002·122 cites·2 claims
- 2693US6277830B15′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferonSCHERING CORP·Filed 1999·Granted Aug 21, 2001·120 cites·43 claims
- 2793US5750532APharmaceutically active compoundsSCHERING CORP·Filed 1995·Granted May 12, 1998·68 cites·3 claims
- 2893US4530793AProcesses for the production of penemsSCHERING CORP·Filed 1982·Granted Jul 23, 1985·30 cites·3 claims
- 2992US7399749B2Substituted prolines as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Jul 15, 2008·21 cites·26 claims
- 3092US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 3192US5039676ATri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereofSCHERING CORP·Filed 1990·Granted Aug 13, 1991·54 cites·12 claims
- 3291US7253160B2Depeptidized inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2004·Granted Aug 7, 2007·39 cites·44 claims
- 3391US7119200B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2004·Granted Oct 10, 2006·45 cites·13 claims
- 3491US6225322B1Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1998·Granted May 1, 2001·59 cites·20 claims
- 3591US4443373AProcess for the production of antibiotic penemsSCHERING CORP·Filed 1982·Granted Apr 17, 1984·27 cites·16 claims
- 3689USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 3789US6096757AMethod for treating proliferative diseasesSCHERING CORP·Filed 1998·Granted Aug 1, 2000·91 cites·21 claims
- 3888US7161003B1Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jan 9, 2007·32 cites·31 claims
- 3987US6362188B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Mar 26, 2002·85 cites·29 claims
- 4087US5714490ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Feb 3, 1998·37 cites·20 claims
- 4186US6333333B1Methods for treating proliferative diseasesSCHERING CORP·Filed 2000·Granted Dec 25, 2001·22 cites·24 claims
- 4285US8673924B2Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsGUZI TIMOTHY J·Filed 2007·Granted Mar 18, 2014·11 cites·25 claims
- 4385US6903131B23,4-di-substituted maleimide compounds as CXC chemokine receptor antagonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Jun 7, 2005·28 cites·21 claims
- 4484US7468372B2Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Dec 23, 2008·7 cites·13 claims
- 4584US5516784AAnti-HIV (AIDS) agentsSCHERING CORP·Filed 1992·Granted May 14, 1996·26 cites·18 claims
- 4683US8067379B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseBENNETT FRANK·Filed 2005·Granted Nov 29, 2011·8 cites·43 claims
- 4783US7449447B2Peptidomimetic NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2004·Granted Nov 11, 2008·20 cites·41 claims
- 4882US7619094B2Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virusSCHERING CORP·Filed 2006·Granted Nov 17, 2009·5 cites·33 claims
- 4982US7078525B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jul 18, 2006·15 cites·27 claims
- 5080US7138396B217 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseasesSCHERING CORP·Filed 2005·Granted Nov 21, 2006·3 cites·12 claims
Showing the top 50 of 142 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Viyyoor M. Girijavallabhan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →